Browse articles from EyeWorld.org related to Fuchs. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

EyeWorld Weekly, August 13, 2021

➤ Orphan drug designation granted for retinitis pigmentosa treatment ➤ Licensing agreement for progressive myopia treatment ➤ Study: Gene editing prevents Fuchs in mice ➤ Enrollment complete for Phase 3 program evaluating anti-inflammatory, immunomodulation drug for DED ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, August 13, 2021

EyeWorld Weekly, May 14, 2021

➤ FDA approves new presbyopia-correcting IOL ➤ New way to evaluate sickle cell retinopathy ➤ Positive Phase 2a data on novel, topical dry eye disease drug candidate ➤ Second Phase 3 trial initiated for Demodex blepharitis treatment ➤ Large-scale, randomized controlled trial replicated with real-world data set ➤ ASCRS events

Comments Off on EyeWorld Weekly, May 14, 2021

EyeWorld Weekly, February 19, 2021

➤ Investigating adjuvant therapy to DSO for Fuchs ➤ FDA approves loteprednol etabonate ophthalmic gel ➤ Pilot study: Photobiomodulation improves BCVA in patients with dry AMD ➤ Positive interim data in trial for gene therapy for GA ➤ Four Phase 3 studies of faricimab show up to 4-month treatment intervals for DME and wet AMD

Comments Off on EyeWorld Weekly, February 19, 2021